Cargando…

Member-Focused, Member-Driven

Detalles Bibliográficos
Autor principal:	Sauer, Kevin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Practice Applications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450560/ http://dx.doi.org/10.1016/j.jand.2021.08.107

Ejemplares similares

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research
por: Kandiyali, Rebecca, et al.
Publicado: (2018)

Semper firmus, pharmacists as versatile team members
por: Galdun, Patrick, et al.
Publicado: (2020)

Family Focused Therapy for Family Members of Patients with Bipolar Disorder: Case Reports of Its Impact on Expressed Emotions
por: Padmavathi, N., et al.
Publicado: (2020)

Classification and analysis of asynchronous communication content between care team members involved in breast cancer treatment
por: Steitz, Bryan D, et al.
Publicado: (2021)

Professional Practice Committee Members
Publicado: (2011)

Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
por: Williams, Jake T. W., et al.
Publicado: (2022)

Involving im/migrant community members for knowledge co-creation: the greater the desired involvement, the greater the need for capacity building
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2021)

Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States
por: Xie, Richard Z., et al.
Publicado: (2021)

Conducting Trial-Based Economic Evaluations Using R: A Tutorial
por: Ben, Ângela Jornada, et al.
Publicado: (2023)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario
por: Duarte, Flavia A., et al.
Publicado: (2022)

Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic
por: Day, Alice S., et al.
Publicado: (2021)

Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
por: Kareva, Irina, et al.
Publicado: (2021)

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency
por: Shields, Gemma E., et al.
Publicado: (2021)

Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future Directions
por: Nowell, W. Benjamin, et al.
Publicado: (2021)

Conducting Qualitative Research Online: Challenges and Solutions
por: Carter, Stacy M., et al.
Publicado: (2021)

Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia
por: Reyes-Travé, Anna, et al.
Publicado: (2021)

How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
por: Clarke, Caroline S., et al.
Publicado: (2021)

A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
por: Seo, Mikyung Kelly, et al.
Publicado: (2021)

Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021)

Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines
por: Painter, Chris, et al.
Publicado: (2021)

Mixture Cure Models in Oncology: A Tutorial and Practical Guidance
por: Felizzi, Federico, et al.
Publicado: (2021)

Future Trends and the Pace of Change: Are We Ready?: The COVID-19 pandemic has presented an undeniable case for change. Life, work and organizations will never be “back to normal.” This opens up massive opportunities to raise our awareness of future trends and to elevate our profession, build resilience, increase our influence and visibility, and infuse futuristic competencies into our educational programs and practices.
por: Farr, Linda T.
Publicado: (2021)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
por: Petrou, Stavros, et al.
Publicado: (2015)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

A training paradigm to enhance performance and safe use of an innovative neuroendovascular device
por: Ricci, Donald R., et al.
Publicado: (2016)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
por: Whitehurst, David G. T., et al.
Publicado: (2018)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage
por: Maniadakis, Nikolaos, et al.
Publicado: (2018)

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
por: Shen, Jing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c8qrrm5hf0f9pjl00u6uv6adg1